Drug giant AstraZeneca attempted to obscure the connection between one of its blockbuster drugs and diabetes risk for years after it knew of the problem, according to documents recently unsealed as part of lawsuits against the company.
Antidepressant use more than doubled in the United States between 1996 and 2005, according to a study conducted by researchers from the University of Columbia and University of Pennsylvania and published in the Archives of General Psychiatry.
Now, the Senate Subcommittee on Oversight of Government Management, chaired by Democratic Sen. Daniel Akaka of Hawaii, has asked the Government Accountability Office to look into the drugging of foster care children. The investigators will attempt to account for estimates in the hundreds of millions of dollars of possible fraud arising from prescriptions for drugs explicitly barred from Medicaid coverage. The GAO is collecting data from Oregon, Massachusetts, Florida, Maryland, Minnesota, and Texas, to search for patterns of abuse.
It turns out you don’t need to have Attention Deficit Hyperactivity Disorder in order to get the prescription drugs that treat it – you just have to know how to fake it.
The risk of coronary heart disease and a cluster of conditions known as metabolic syndrome increases soon after otherwise healthy, but depressed people are started on psychiatric drugs, putting them at risk for an early death, Canadian researchers are reporting.
SHARE YOUR STORY/COMMENT: